Thank you, Paul. The continued momentum in both our U.S. and international businesses during Q3 saw over 14 million average ...
Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q ...
Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Khadija Khartit is a strategy, investment, and funding expert, and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback